Barbara Frigeni

Author PubWeight™ 12.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. J Peripher Nerv Syst 2007 2.01
2 Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients. J Neurol Neurosurg Psychiatry 2013 1.55
3 Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Hypertension 2011 1.54
4 Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools. Eur J Cancer 2010 1.50
5 Chemotherapy-induced neuropathy. Curr Treat Options Neurol 2011 0.99
6 Learning disorders in epilepsy. Epilepsia 2006 0.99
7 Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity. J Peripher Nerv Syst 2008 0.86
8 A review of the costs of managing childhood epilepsy. Pharmacoeconomics 2005 0.85
9 TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy. Neurol Sci 2014 0.80
10 Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study. J Peripher Nerv Syst 2014 0.79
11 Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study. J Peripher Nerv Syst 2014 0.77
12 Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue. Pain Manag 2013 0.75
13 Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study. Neurology 2017 0.75